Dr. Housri Discusses theMednet

Video

Nadine Housri, MD, assistant clinical professor, Yale School of Medicine, discusses theMednet.

Newsletter

Stay up to date on practice-changing data in community practice.

Subscribe Now!
Recent Videos
Why Are Young Adults Getting More Pancreatic & Colon Cancer?
Why Are Young Adults Getting More Pancreatic & Colon Cancer?
Younger Adults See Sharp Rise in Pancreas & Colon Cancer, Study Shows
Younger Adults See Sharp Rise in Pancreas & Colon Cancer, Study Shows
The Growing Financial Burden on Patients and Caregivers in Cancer Care
The Growing Financial Burden on Patients and Caregivers in Cancer Care
Caregiver & Housing Hurdles: Equity in HCT & CAR T Treatment
Caregiver & Housing Hurdles: Equity in HCT & CAR T Treatment
HCT & CAR T Access: Unseen Barriers & Inequities in Care
HCT & CAR T Access: Unseen Barriers & Inequities in Care
Weiss on How Nanoparticles are Enhancing Radiation Therapy in Lung Cancer
Weiss on How Nanoparticles are Enhancing Radiation Therapy in Lung Cancer
Navigating the Complexities of Immunotherapy in ALL
Navigating the Complexities of Immunotherapy in ALL
First-Line CLL/SLL: Is Chemo-Free the Future?
First-Line CLL/SLL: Is Chemo-Free the Future?
SC Pembrolizumab Noninferior to IV in NSCLC: Phase 3 Trial Results
SC Pembrolizumab Noninferior to IV in NSCLC: Phase 3 Trial Results
Elmariah on the Evolving Role of Fedratinib
Elmariah on the Evolving Role of Fedratinib
Related Content
Exploring HIFU in Early to Intermediate Prostate Cancer Treatment

Exploring HIFU in Early to Intermediate Prostate Cancer Treatment

Jordyn Sava
April 21st 2025
Article

Alexander Kenigsberg, MD, discusses a new nonsurgical, robotic-focused ultrasound procedure for prostate cancer.

Read More

Leighl Covers PALOMA-3 Trial of SC Amivantamab in NSCLC

Leighl Covers PALOMA-3 Trial of SC Amivantamab in NSCLC

Jordyn Sava
April 18th 2025
Article

Natasha Leighl, MD, MMSc, BSc, discussed key findings from the PALOMA-3 trial for a community oncologist audience.

Read More

Novel Radioenhancer JNJ-1900 Shows Potential Across Cancers

Novel Radioenhancer JNJ-1900 Shows Potential Across Cancers

Jordyn Sava
April 15th 2025
Article

Jared Weiss, MD, discussed the mechanism of action of JNJ-1900 and the preliminary data presented at the 2025 European Lung Cancer Congress.

Read More

COA Advocates for Biomarker Testing Access, Physician Autonomy in Cancer Care

COA Advocates for Biomarker Testing Access, Physician Autonomy in Cancer Care

Jordyn Sava
April 11th 2025
Article

Nicolas Ferreyros discussed central ideas from the Community Oncology Alliance to optimize cancer care in community oncology settings.

Read More

Teclistamab Combo Yields Deep Responses in Newly Diagnosed Myeloma

Teclistamab Combo Yields Deep Responses in Newly Diagnosed Myeloma

Jordyn Sava
April 10th 2025
Article

Marc Raab, MD, PhD, discussed the MajesTEC-5 trial of teclistamab plus standard myeloma therapies in transplant-eligible newly diagnosed multiple myeloma.

Read More

Strong 1-Year Survival Shown With MMUD Peripheral Blood Stem Cell Transplants

Strong 1-Year Survival Shown With MMUD Peripheral Blood Stem Cell Transplants

Jordyn Sava
April 8th 2025
Article

Jeff Auletta, MD, discussed the ACCESS trial and explained that mismatched unrelated donor transplants can be a viable option.

Read More